The International Prognostic Scoring System for Waldenström’s macroglobulinemia is applicable in patients treated with rituximab-based regimens
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Ferrata Storti Foundation
2008-09-01
|
Series: | Haematologica |
Online Access: | https://haematologica.org/article/view/5012 |